Acute kidney injury following induction of chemotherapy: Diagnosis and management in critical care. (February 2023)

• Record Type: Journal Article
• Authors: Chapman, Robert; Shah, Sita; D'Angelo, Alberto
• Is Part Of: Journal of the Intensive Care Society. Volume 24:Number 1(2023)
• Page Start: 112
• Page End: 116
• Publication Date: 2023-02
• Subjects: Critical care -- haematology -- oncology -- tumour lysis syndrome -- renal replacement therapy -- hyperkalaemia -- electrolyte disturbance; Critical care medicine -- Periodicals; Intensive care units -- Periodicals; 616.028
• DOI: 10.1177/17511437221106441
• Languages: English
• ISSNs: 1751-1437

Abstract

A 48-year-old gentleman who had recently commenced chemotherapy for diffuse B-cell lymphoma was admitted to hospital with nausea and generalised weakness. He developed abdominal pain and oliguric acute kidney injury with multiple electrolyte derangements and was transferred to the intensive care unit (ICU). His condition deteriorated, requiring endotracheal intubation and renal replacement therapy (RRT). Tumour lysis syndrome (TLS) is a common and life-threatening complication of chemotherapy and represents an oncological emergency. TLS affects multiple organ systems and is best managed in the ICU with closer monitoring of fluid balance, serum electrolytes, cardiorespiratory and renal function. TLS patients may go on to require mechanical ventilation and RRT. TLS patients require input from a large multidisciplinary team of clinicians and allied health professionals.